Chemcon Speciality Chemicals Ltd

AI
Chemcon Special. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Chemcon Speciality Chemicals Ltd

₹ 212 -1.56%
05 Oct 1:50 p.m.
cscpl.com BSE: 543233 NSE: CHEMCON
About

Incorporated in 1988, Chemcon Speciality Chemicals Ltd manufactures Pharmaceutical intermediates and Oilfield Chemicals[1]

Key Points

Business Overview:[1]
CSCL is an ISO 9001:2015 and ISO 14001:2015 certified manufacturer of silanes, pharma intermediates, agro intermediates, and oil field chemicals. It is the largest manufacturer of specialised chemicals like HMDS and CMIC, predominantly used in the pharmaceutical industry.

Website BSE NSE
  • Market Cap ₹ 777 Cr.
  • Current Price ₹ 212
  • High / Low ₹ 288 / 125
  • Stock P/E 27.6
  • Book Value ₹ 132
  • Dividend Yield 3.07 %
  • ROCE 6.35 %
  • ROE 4.70 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's working capital requirements have reduced from 161 days to 108 days

Cons

  • The company has delivered a poor sales growth of -0.29% over past five years.
  • Company has a low return on equity of 4.61% over last 3 years.
  • Earnings include an other income of Rs.15.5 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
79 75 53 60 46 53 54 55 54 54 57 75 66
72 67 47 55 38 44 43 49 46 47 51 67 51
Operating Profit 8 8 6 4 7 9 11 6 8 7 7 9 15
OPM % 10% 11% 12% 7% 16% 16% 21% 11% 15% 13% 12% 12% 23%
4 3 3 3 4 4 4 3 4 4 4 4 4
Interest 1 1 1 1 1 1 1 1 0 0 1 1 1
Depreciation 3 3 3 3 3 3 3 3 3 3 3 3 4
Profit before tax 8 8 6 4 7 9 12 5 8 8 7 9 15
Tax % 26% 26% 27% 30% 27% 26% 26% 27% 24% 28% 25% 28% 25%
6 6 4 3 5 6 9 4 6 6 5 6 11
EPS in Rs 1.61 1.62 1.21 0.79 1.47 1.73 2.41 1.08 1.74 1.57 1.39 1.74 2.99
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
63 97 88 158 303 262 243 257 303 267 207 240 253
56 87 79 112 237 192 162 175 232 240 174 210 215
Operating Profit 8 10 9 46 66 70 81 82 71 27 33 30 38
OPM % 12% 10% 10% 29% 22% 27% 33% 32% 23% 10% 16% 13% 15%
-1 0 0 0 2 4 5 9 13 13 14 15 15
Interest 2 3 2 3 4 5 4 1 1 4 3 2 3
Depreciation 2 2 2 2 3 5 6 6 8 10 11 12 13
Profit before tax 3 5 5 41 61 65 76 84 74 26 33 32 38
Tax % 3% 35% 37% 35% 30% 25% 26% 25% 26% 27% 26% 26%
3 3 3 26 43 49 56 63 55 19 24 24 28
EPS in Rs 3.35 4.09 3.78 33.21 13.54 15.37 15.40 17.13 15.04 5.24 6.67 6.44 7.69
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 27% 0% 0% 101%
Compounded Sales Growth
10 Years: 10%
5 Years: 0%
3 Years: -7%
TTM: 17%
Compounded Profit Growth
10 Years: 22%
5 Years: -16%
3 Years: -25%
TTM: 11%
Stock Price CAGR
10 Years: %
5 Years: -14%
3 Years: -8%
1 Year: -20%
Return on Equity
10 Years: 13%
5 Years: 8%
3 Years: 5%
Last Year: 5%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 8 8 8 8 32 32 37 37 37 37 37 37
Reserves 13 16 19 46 65 115 317 381 421 440 464 447
12 13 20 17 33 46 6 36 64 43 25 53
10 9 15 27 43 34 44 45 32 26 29 32
Total Liabilities 44 46 63 97 173 226 404 498 553 545 554 568
20 19 24 30 40 49 67 82 141 146 149 195
CWIP 0 0 0 0 1 4 9 34 14 42 40 21
Investments 0 0 0 0 0 0 0 0 0 0 10 10
24 27 38 67 133 173 328 382 398 356 355 342
Total Assets 44 46 63 97 173 226 404 498 553 545 554 568

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
7 5 10 14 11 12 65 74 13 12 38 42
-5 -2 -9 -7 -24 -16 -152 -92 -16 -25 -17 -35
-3 -3 -2 -6 12 4 111 30 12 -25 -22 -3
Net Cash Flow -1 -0 -1 1 -0 0 23 11 9 -37 0 3
Free Cash Flow 3 3 2 7 -2 -2 34 24 -32 -31 29 32
CFO/OP 105% 65% 130% 62% 51% 41% 99% 119% 49% 78% 124% 163%

Ratios

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 52 51 93 68 77 124 142 146 81 112 91 97
Inventory Days 74 45 58 99 91 118 175 102 164 119 261 158
Days Payable 79 39 81 82 57 63 67 70 44 23 49 42
Cash Conversion Cycle 47 57 70 86 111 179 250 177 201 208 303 212
Working Capital Days 64 59 8 61 59 135 184 105 108 162 211 108
ROCE % 17% 22% 16% 74% 65% 43% 29% 21% 15% 6% 7% 6%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export Revenue Share
%

Log in to view insights

Please log in to see hidden values.

Login
Organic Chemicals Revenue Share
%
Sales Volume - Inorganic Chemicals (Bromides)
MT
Sales Volume - Organic Chemicals
MT
Total Sales Volume
MT
Top 10 Customer Concentration
%
Installed Capacity - Inorganic Chemicals (Bromides)
MTPA
Installed Capacity - Organic Chemicals
MTPA

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
74.47% 74.47% 74.47% 74.47% 74.47% 74.47% 74.47% 74.47% 74.47% 74.47% 74.47% 74.47%
0.01% 0.05% 0.25% 0.25% 0.25% 0.25% 0.32% 0.30% 0.27% 0.32% 0.38% 0.25%
0.27% 0.28% 0.27% 0.27% 0.27% 0.27% 0.27% 0.00% 0.00% 0.00% 0.00% 0.00%
25.24% 25.20% 25.01% 25.01% 25.01% 25.01% 24.94% 25.24% 25.27% 25.21% 25.15% 25.28%
No. of Shareholders 83,50981,36779,10876,38973,82772,42670,72369,52769,21166,85064,98664,587

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls